Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.55 USD | +0.83% | -3.08% | +0.71% |
12:33pm | Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating | MT |
05-13 | Transcript : Voyager Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.71% | 461M | |
+27.42% | 48.16B | |
-0.77% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.54% | 25.59B | |
-22.83% | 18.96B | |
+8.11% | 12.92B | |
+29.29% | 12.03B | |
-2.07% | 11.77B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Voyager Therapeutics : Chardan Adjusts Price Target on Voyager Therapeutics to $6.50 From $15, Maintains Neutral Rating